Suppr超能文献

电压依赖性钙通道在细胞周期的两个阶段调节GH4垂体细胞增殖。

Voltage-dependent calcium channels regulate GH4 pituitary cell proliferation at two stages of the cell cycle.

作者信息

Ramsdell J S

机构信息

Department of Anatomy and Cell Biology, Medical University of South Carolina, Charleston 29425.

出版信息

J Cell Physiol. 1991 Feb;146(2):197-206. doi: 10.1002/jcp.1041460203.

Abstract

Calcium is an intracellular signal implicated in the regulation of cell proliferation. We have examined the growth regulatory role of voltage-dependent calcium channels (VDCC) in a rat pituitary cell line (GH4C1) that expresses two well-characterized VDCC subtypes (L and T) and is growth-inhibited by several agents known to enhance calcium entry. Thyrotropin-releasing hormone (TRH), tetradecanoylphorbol acetate (TPA), and epidermal growth factor (EGF), each known to enhance calcium entry in GH4 cells, decrease GH4 cell number and incorporation of [3H]-thymidine. The growth inhibitory action of these agents is cytostatic with a predominant effect to block G1 cells from entering S-phase. We next examined the growth regulatory action of pharmacologic agents that interact directly and specifically with type L VDCC. Activation of type L VDCC with the dihydropyridine BAY K8644 inhibits GH4 proliferation as measured by cell number and [3H]-thymidine incorporation. This action of BAY K8644 is enhanced by a submaximal K(+)-maintained depolarization, and the growth inhibitory action of these agents is also cytostatic as evident by the block of G1 cells from entering S-phase. Nimodipine, an antagonist specific for type L VDCC blocks (IC50 = 30 nM) BAY K8644-inhibited cell proliferation by substantially reducing the S-phase block. Taken together these findings indicate that calcium entry through type L VDCC inhibits GH4 cell proliferation by blocking entry into S-phase. By contrast, nimodipine caused only a small reversal of the TRH-induced S-phase block, suggesting that TRH inhibits proliferation by a mechanism that differs at least in part from L-channel activation. Unexpectedly, nimodipine, given alone, caused a substantial inhibition of GH4 cell proliferation. This action of nimodipine was cytostatic, yet differed from calcium channel activators in that the percentage of S-phase cells was unchanged whereas G2-M-phase cells increased with a parallel decrease in G1-phase cells. Similar effects were also observed with other classes of calcium channel blockers. Taken together these results indicate that calcium entry through VDCC regulates GH4 cell proliferation differently depending on the stage of the cell cycle. In G1-phase cells, sustained entry of calcium through type L VDCC blocks entry into S-phase. In G2-M-phase cells entry of calcium promotes progression through mitosis.

摘要

钙是一种参与细胞增殖调控的细胞内信号分子。我们研究了电压依赖性钙通道(VDCC)在大鼠垂体细胞系(GH4C1)中的生长调节作用,该细胞系表达两种特征明确的VDCC亚型(L型和T型),并且已知几种能增强钙内流的药物可抑制其生长。促甲状腺激素释放激素(TRH)、十四酰佛波醇乙酸酯(TPA)和表皮生长因子(EGF),已知它们均可增强GH4细胞中的钙内流,减少GH4细胞数量以及[3H] - 胸腺嘧啶核苷的掺入。这些药物的生长抑制作用是细胞周期停滞性的,主要作用是阻止G1期细胞进入S期。接下来,我们研究了直接且特异性地与L型VDCC相互作用的药物的生长调节作用。用二氢吡啶BAY K8644激活L型VDCC可抑制GH4细胞增殖,这通过细胞数量和[3H] - 胸腺嘧啶核苷掺入量来衡量。BAY K8644的这种作用在亚最大钾离子维持的去极化作用下增强,并且这些药物的生长抑制作用同样是细胞周期停滞性的,这从G1期细胞进入S期受阻可以明显看出。尼莫地平,一种L型VDCC的特异性拮抗剂(IC50 = 30 nM),通过大幅减少S期阻滞来阻断BAY K8644抑制的细胞增殖。综合这些发现表明,通过L型VDCC的钙内流通过阻止进入S期来抑制GH4细胞增殖。相比之下,尼莫地平仅能部分逆转TRH诱导的S期阻滞,这表明TRH抑制增殖的机制至少部分不同于L通道激活。出乎意料的是,单独给予尼莫地平会导致GH4细胞增殖的显著抑制。尼莫地平的这种作用是细胞周期停滞性的,但与钙通道激活剂不同,因为S期细胞的百分比没有变化,而G2 - M期细胞增加,同时G1期细胞平行减少。在其他类别的钙通道阻滞剂中也观察到了类似的效果。综合这些结果表明,通过VDCC的钙内流根据细胞周期的阶段不同地调节GH4细胞增殖。在G1期细胞中,通过L型VDCC持续的钙内流阻止进入S期。在G2 - M期细胞中,钙内流促进有丝分裂进程。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验